Background: Acetylcodeine (AC), an impurity of illicit heroin synthesis, has been suggested as an interesting biomarker of illicit heroin use. Methods: Procedures were developed for quantification of (a) morphine, 6-monoacetylmorphine (6-AM), and codeine in urine and (b) diacetylmorphine and AC in urine. Solid-phase extraction of the analytes was performed, and the extracted analytes were analyzed by selected-ion monitoring with gas chromatography-mass spectrometry. This procedure required prior derivatization with propionic anhydride. Results: Different validation parameters were determined, such as linearity, reproducibility, extraction recoveries, and cutoffs. Seventy-one urine specimens of illicit heroin abusers and 44 urine specimens of subjects in a heroin maintenance program were analyzed. AC was detected in 85.9% of the samples of the first group but not in any of the samples from subjects taking medical heroin. In the two groups, there were 94.4% and 84.1% 6-AM positive urine specimens, respectively. Detection times were determined for AC and codeine by parallel administration of heroin containing various percentages of AC to four voluntary patients in a heroin maintenance program. The measured detection times were 8 and 23 h for AC and codeine, respectively. Conclusions: These results indicate that, together with detection of 6-AM in urine, AC is a suitable marker of illicit heroin use.
and to distinguish heroin use from codeine or morphine use. However, interpretation of positive morphine results can be difficult because of the presence of opiate alkaloids in medicines and foods. For example, morphine and codeine are present in many preparations for the treatment of pain and cough suppression. In addition, they are found in various amounts in opium poppy seed (4 ), a common ingredient of bakery products. Ingestion of these products leads to excretion of codeine and morphine in urine.
As illustrated in Fig. 1 , both codeine and heroin are metabolized into morphine, which is then excreted in the urine. Therefore, detection of morphine in urine can result from intake of heroin, morphine, codeine, or poppy seeds.
6-Monoacetylmorphine (6-AM) 4 in urine has been suggested as a specific marker of heroin abuse, and several methods for its detection have been reported (5) (6) (7) (8) . The detection time measured for 6-AM is short (Ͻ8 h), whereas the detection times for other metabolites, such as morphine, are longer.
In addition to 6-AM, acetylcodeine (AC) has been suggested recently as another marker of illicit heroin use (9 ) . AC is a manufacturing impurity (1-15%) of heroin (10 ) and is metabolized into codeine and, subsequently, into morphine (Fig. 1) .
In 1994, the Swiss Federal Office of Public Health started a new heroin maintenance program in which addicted patients receive heroin under governmental supervision. Here, AC could be useful in monitoring addicts enrolled in such programs. Because the maintenance heroin administered is pure (Ͻ0.1% AC), the presence of AC in the urine of these patients indicates that they may be supplementing their supervised heroin doses with illicit heroin.
The role of AC in urine as a specific indicator of illicit heroin use depends on two main factors: (a) the availability of a reliable and sensitive analytical method for AC detection and, subsequently, availability of other opiate detection methods; and (b) an adequate detection time for AC and codeine in urine. Two separate procedures were validated and applied to urine specimens from patients in a heroin maintenance program and from illicit heroin users. This report also describes a study on AC excretion in urine. Four volunteer patients in a heroin maintenance program agreed to take heroin with various percentages of AC, which allowed us to determine detection times for AC and codeine.
Materials and Methods chemical reagents and instrumentation
The acid, buffer, solvents, and pyridine were provided by Merck. Propionic anhydride was supplied by Aldrich.
Drugs and nalorphine were obtained from Cambridge Isotope Laboratories and Sigma. Bond Elut Certify cartridges (sorbent type, C 8 and SO 3 H; weight, 130 mg) were obtained from Varian and used for the extractions. Urine analyses were performed using a Hewlett Packard 5890 gas chromatograph equipped with a mass-selective detector (Model 5972; Hewlett Packard) that operated in electron-impact mode with an energy of 70 eV.
dose and specimen collection
Urine specimens were obtained from illegal heroin users and subjects enrolled in the Prove Program, a medical heroin treatment program set up by the Swiss Federal Office of Public Health. Volunteers of the Prove Program received 120 -750 mg of heroin intravenously per day. Urine specimens were collected at least 3 months after the beginning of the treatment. For the group of illegal heroin consumers, the indicated heroin daily dose was based on the consumers' declarations.
Immunoassay screening was performed on all urine specimens using the following tests, cutoff values, and reference substances: amphetamines (d-methamphetamine, 1000 g/L); barbiturates (secobarbital, 200 g/L); benzodiazepines (nordazepam, 100 g/L); cannabis (11-nor-⌬-9-THCCOOH, 50 g/L); cocaine (benzoylecgonine, 300 g/L); methadone (300 g/L); methaqualone (300 g/L); tricyclic antidepressants (nortriptyline, 300 g/L); and d-lysergic acid diethylamide (LSD, 0.5 g/L).
Three heroin consumers were excluded from the study because only morphine was found in their urine and the concentration was Ͻ100 g/L. This lower concentration could be explained by too long of a period between heroin consumption and urine sampling. Subject characteristics and parallel consumption (results of immunoassay screening) for the two groups are summarized in Tables 1 and 2 . A third group included four voluntary patients in a heroin maintenance program who agreed to take heroin containing various percentages of AC. To simulate parallel consumption of illicit heroin, they received heroin containing various percentages of AC during 36 days in the following manner: (a) between days 2 and 9, heroin contained 9% AC; (b) during days 12 and 13, heroin contained 5% AC; and (c) between days 19 and 26, heroin contained 3% AC. Pure heroin was administered on days 1, 10, 11, 14 -18, and 27-36.
All patients received their daily heroin in three doses, and only the morning dose contained AC. Table 3 summarizes dose characteristics for the four patients. During days 2, 12, and 19, urine specimens were collected at 0, 1, 3, 6, 12, and 24 h after the morning dose. Urine collections performed at 0, 6, 12, and 24 h were just prior to administration of the next dose of heroin. All urine specimens were stored at Ϫ20°C until analysis. We found that AC was very stable in these storage conditions because there was no loss after 6 months of storage.
The study was conducted according to the guidelines for the protection of human subjects, and each volunteer provided informed consent.
sample preparation Nalorphine (300 L of a 25 mg/L solution) was added to 1 mL of urine for procedure A (morphine, 6-AM, and codeine), and nalorphine (200 L of a 2.5 mg/L solution) was added to 2 mL of urine for procedure B (heroin and AC).
Urine specimens were then extracted by the same technique with Bond Elut Certify columns. This consisted of conditioning the column with 2 mL of methanol, followed by 2 mL of deionized water. Samples were added to the columns, and the columns were then rinsed with 2 mL of deionized water, 2 mL of 0.1 mol/L acetate buffer (pH 4), and 2 mL of methanol. Columns were dried under reduced pressure (10 mmHg) for 5 min, then eluted with 2 mL of methylene chloride-isopropanol (4:1 by volume) containing 20 mL/L ammonium hydroxide. The eluate was dried under nitrogen.
Pyridine and propionic anhydride (100 L each) were then added, and samples were heated at 60°C for 30 min. After derivatization, the reagent was dried under nitrogen, and the samples were reconstituted with 50 L of ethyl acetate.
gas chromatography-mass spectrometry (gc-ms)
For GC, a DB-5MS capillary column (15 m ϫ 0.25 mm; 0.25-m film thickness; J & W Scientifics) was used with helium as the carrier gas. The following temperatures were applied: 170°C maintained for 1 min; ramped to 240°C at 20°C/min, to 256°C at 2°C/min, and to 270°C at 10°C/min; and then held at 270°C for 0.6 min. The injector temperature was 270°C, and injection was made in splitless mode. The interface temperature was 280°C.
The sample (2 L) was injected into the GC-MS system, which was operating in selected-ion monitoring mode. The electron multiplier voltage was set at the EI-tune voltage for procedure A and at ϩ200 V above EI-tune voltage for procedure B.
The following ions were monitored: for procedure A, morphine (m/z 397 and 341), 6-AM (m/z 383 and 327), codeine (m/z, 355 and 282), and nalorphine (m/z 423 and 367); and for procedure B, heroin (m/z 369 and 327), AC (m/z 341 and 282), and nalorphine (m/z 423 and 367).
The internal ratio for each compound was monitored. Quantification was based on the peak-area ratios (the first ion listed for each compound was used) of the analytes to the internal standard (nalorphine).
validation protocol
Extraction recovery was determined by adding the analytes to drug-free urine at low and high concentrations (n ϭ 6). After extraction, nalorphine was added as an external standard, and peak-area ratios were then compared with unextracted calibrators of equal concentrations in methanol or in acetonitrile for AC. Reproducibility (within-run precision) was determined by analysis of a low and high concentration of each analyte on the same day (n ϭ 6). Seven-point calibration curves for each analyte were analyzed to determine method linearity. The limit of quantification (LOQ) was determined as the lowest concentration yielding a result within Ϯ 20% of the target concentration and with a CV Ͻ10%.
Results
These two procedures permitted the determination of five opiates: morphine, 6-AM, codeine, heroin, and AC. The analytes were determined with the following retention times: for procedure A, 8.60 min (morphine), 7.65 min (6-AM), and 6.55 min (codeine); and for procedure B, 6.75 min (heroin) and 5.85 min (AC).
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The quantitative excretion patterns for free morphine, 6-AM, codeine, AC, and heroin were determined by GC-MS after administration of pure heroin containing 0 -9% AC to four male subjects. Data are presented in Tables 8 and 9 . Peak concentrations of free morphine, 6-AM, and codeine occurred within 1-2 h after intake. Peak concentrations of AC were not different from those of other opiates, and only free morphine and 6-AM were detected in the morning urine specimens.
The quantitative excretion patterns for all previously mentioned opiates were determined after administration of pure medical heroin. Neither AC nor codeine was detected, which demonstrates that AC is excreted in urine only when AC is present in heroin and that codeine is the main metabolite of AC.
Detection times are important markers in forensic drug testing because they indicate how long after drug administration a subject excretes a drug or a metabolite at a concentration above a specific assay cutoff (i.e., they show how long a subject tests positive for a drug) (7 ) . The detection times by GC-MS for AC and codeine in four male subjects are shown in Tables 8 and 9 . The two assigned cutoffs were 1 and 10 g/L, respectively. Mean detection times (Ϯ SD) were 8 Ϯ 4 h for AC and 23 Ϯ 4 h for codeine.
Discussion
Our data demonstrate that AC is a good biomarker of illicit heroin use as demonstrated previously by O'Neal and Poklis (10 ) . In their study, AC was detected in only 37% of the urine specimens, in contrast to ϳ86% in our study. This difference in rates could be explained by the longer period between heroin consumption and urine sampling or by the lower AC content in the heroin administered in their study.
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in the heroin maintenance program who had volunteered for the experiment. The measured detection time of 8 Ϯ 4 h was close to that of 6-AM (7 ). This study also clearly demonstrates that the presence of codeine in urine could be caused by either codeine or illicit heroin consumption. However, with a measured detection time of 23 Ϯ 4 h, codeine remains a much less specific marker of illicit heroin use than AC.
In conclusion, this study shows that, together with the detection of 6-AM in urine, AC is a suitable marker of illicit heroin use.
